We are live on ! Find out more
Temasek Holdings

Temasek Holdings Portfolio holdings

AUM $37.3B
1-Year Est. Return 12.6%
This Fund
S&P 500
This Quarter Est. Return
+3.74%
1 Year Est. Return
+12.6%
3 Year Est. Return
+93.72%
5 Year Est. Return
+64.47%
10 Year Est. Return
+501.94%
AUM
$19B
AUM Growth
+$790M
Cap. Flow
+$345M
Cap. Flow %
1.81%
Top 10 Hldgs %
70.05%
Holding
71
New
1
Increased
12
Reduced
5
Closed
9

Top Buys

Rank Stock Value
1
LUMN icon
Lumen
LUMN
+$315M
2
HDB icon
HDFC Bank
HDB
+$75M
3
GPN icon
Global Payments
GPN
+$70.9M
4
MA icon
Mastercard
MA
+$35.4M
5
PYPL icon
PayPal
PYPL
+$35.3M

Top Sells

Rank Stock Value
1
VIRT icon
Virtu Financial
VIRT
+$111M
2
MON
Monsanto Co
MON
+$50.1M
3
BABA icon
Alibaba
BABA
+$19.6M
4
AMRS
Amyris Inc.
AMRS
+$17.6M
5
AMZN icon
Amazon
AMZN
+$10.1M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 39.73%
2 Communication Services 16.33%
3 Healthcare 14.87%
4 Financials 10.64%
5 Energy 6.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BABA icon
1
Alibaba
BABA
$281B
$6.59B 34.62%
35,495,289
-102,700
-0.3% -$19.6M
LUMN icon
2
Lumen
LUMN
$6.98B
$2.3B 12.07%
123,201,207
+17,339,784
+16% +$315M
GILD icon
3
Gilead Sciences
GILD
$187B
$788M 4.14%
11,125,816
INFO
4
DELISTED
IHS Markit Ltd. Common Shares
INFO
$767M 4.03%
14,861,018
FTSI
5
DELISTED
FTS International, Inc. Common Stock
FTSI
$593M 3.12%
2,080,857
V icon
6
Visa
V
$700B
$570M 2.99%
4,300,992
+146,290
+4% +$18.8M
PYPL icon
7
PayPal
PYPL
$47B
$507M 2.67%
6,091,124
+443,331
+8% +$35.3M
VIRT icon
8
Virtu Financial
VIRT
$5.69B
$448M 2.36%
16,880,503
-3,450,000
-17% -$111M
DD icon
9
DuPont de Nemours
DD
$17.8B
$402M 2.11%
2,408,549
+35,413
+1% +$5.93M
UNVR
10
DELISTED
Univar Solutions Inc.
UNVR
$369M 1.94%
14,078,012
ONC
11
BeOne Medicines Ltd
ONC
$40.5B
$349M 1.83%
2,270,100
TCOM icon
12
Trip.com Group
TCOM
$25.8B
$346M 1.82%
7,256,928
BMRN icon
13
BioMarin Pharmaceuticals
BMRN
$12.9B
$327M 1.72%
3,472,712
TMO icon
14
Thermo Fisher Scientific
TMO
$227B
$311M 1.64%
1,503,087
JD icon
15
JD.com
JD
$38.2B
$285M 1.5%
7,306,572
MA icon
16
Mastercard
MA
$507B
$283M 1.49%
1,440,714
+188,431
+15% +$35.4M
ZTO icon
17
ZTO Express
ZTO
$15.9B
$244M 1.28%
12,176,750
RDS.B
18
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$208M 1.1%
2,868,867
AR icon
19
Antero Resources
AR
$12.1B
$208M 1.09%
9,755,618
TRQ
20
DELISTED
Turquoise Hill Resources Ltd
TRQ
$208M 1.09%
7,321,388
WP
21
DELISTED
Worldpay, Inc.
WP
$198M 1.04%
2,426,186
+187,938
+8% +$15.4M
PTLA
22
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$195M 1.03%
5,174,168
+290,600
+6% +$11.1M
NFX
23
DELISTED
Newfield Exploration
NFX
$191M 1.01%
6,326,046
ALXN
24
DELISTED
Alexion Pharmaceuticals
ALXN
$187M 0.98%
1,505,325
PPG icon
25
PPG Industries
PPG
$25B
$179M 0.94%
1,727,645

Similar funds

Temasek Holdings's Q2 2018 Portfolio in Review

As of Q2 2018, Temasek Holdings held 71 positions worth $19B, up 4.3% from $18.2B the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Temasek Holdings's Q2 2018 filing shows 1 new, 12 increased, 5 reduced and 9 closed positions. Its largest new stake was ASLAN Pharmaceuticals Limited American Depositary Shares: 35,562 shares worth $12.7M. The largest sale was Virtu Financial, an estimated $111M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 40% of assets, down from 41% a quarter earlier, followed by Communication Services and Healthcare.

  • Temasek Holdings's largest Q2 2018 buy was ASLAN Pharmaceuticals Limited American Depositary Shares: 35,562 shares worth $12.7M.
  • Temasek Holdings added most to Lumen in Q2 2018, an estimated $315M increase.
  • Temasek Holdings's biggest Q2 2018 reduction was Virtu Financial, cutting an estimated $111M.
  • Temasek Holdings fully exited Monsanto Co in Q2 2018, selling an estimated $50.1M.
  • Temasek Holdings's ten largest holdings make up 70% of its $19B portfolio in Q2 2018.
  • Temasek Holdings opened 1 new position and closed 9 in Q2 2018.
  • Temasek Holdings's portfolio value rose 4.3% quarter-over-quarter to $19B.

Based on Temasek Holdings's 13F filing for Q2 2018, filed 14 Aug 2018.